TP53 and cancer: The WGS analysis of a subset of this cohort, consisting of 57 genomes of prostate tumors, identified TMPRSS2-ERG fusions, and recurrent deletion or rearrangement of cancer driver genes PTEN, NKX3-1, CDKN1B, TP53, and RB1 [172].